November 06, 2024

Introduction: CPSR as the Foundation of EU Cosmetic Compliance

Placing a cosmetic product on the European Union market requires strict compliance with the regulatory framework established under Regulation (EC) No 1223/2009. At the core of this regulation is the Cosmetic Product Safety Report (CPSR) a mandatory safety document that demonstrates a product’s safety for human use before market entry.

For manufacturers, brand owners, and Responsible Persons, preparing a CPSR requires scientific rigor, toxicological expertise, and regulatory precision. Maven Regulatory Solutions provides end-to-end CPSR preparation services to ensure full EU compliance, supporting cosmetic brands from formulation review to final safety sign-off.

What Is a Cosmetic Product Safety Report (CPSR)?

The CPSR is a legally required document forming part of the Product Information File (PIF). It is divided into two structured sections:

CPSR SectionPurposeRegulatory Function
Part ACosmetic Product Safety InformationScientific data compilation
Part BCosmetic Product Safety AssessmentExpert toxicological conclusion

Both sections must be completed before product notification via the Cosmetic Products Notification Portal (CPNP).

Part A: Cosmetic Product Safety Information

Part A requires comprehensive scientific data to support the safety evaluation. Maven Regulatory Solutions assists in compiling, reviewing, and generating all required documentation, including laboratory testing where necessary.

1. Quantitative and Qualitative Composition

  • Full INCI listing
  • Exact ingredient concentrations
  • Raw material specifications
  • Identification of restricted or Annex-listed substances

Ingredient compliance must align with Annex II (prohibited substances), Annex III (restricted substances), and Annex V (preservatives) of Regulation (EC) No 1223/2009.

2. Physical and Chemical Characteristics & Stability

Stability testing must demonstrate that the product maintains quality and safety throughout its shelf life.

Typical data include:

  • Accelerated stability testing
  • Compatibility with packaging
  • pH, viscosity, and organoleptic properties
  • PAO (Period After Opening) determination

3. Microbiological Quality

Microbial safety is critical for consumer protection.

Test ParameterPurpose
Total Viable CountDetect contamination
Pathogen ScreeningAbsence of specific harmful microbes
Preservative Efficacy Test (PET)Validate preservation system effectiveness

Microbiological limits must comply with EU safety standards.

4. Impurities, Traces, and Packaging Interaction

  • Heavy metal trace analysis
  • Residual solvents
  • Nitrosamine risk evaluation
  • Migration testing from packaging materials

Packaging compatibility assessments ensure no harmful substance leaches into the formulation.

5. Normal and Foreseeable Use

A detailed usage profile must define:

  • Target population
  • Application frequency
  • Application area
  • Potential misuse scenarios

This supports accurate exposure calculations.

6. Exposure Assessment

Exposure calculations consider:

  • Daily applied quantity
  • Dermal absorption rate
  • Body surface area exposed
  • Consumer age group

Safety assessors calculate Systemic Exposure Dose (SED) to determine safety margins.

7. Toxicological Profile of Ingredients

Each ingredient requires toxicological review, including:

  • Acute toxicity
  • Repeated-dose toxicity
  • Skin irritation and sensitization
  • Genotoxicity
  • Reproductive toxicity
  • Carcinogenicity data (if applicable)

Where animal testing data is unavailable due to EU bans, validated alternative methods and silico models are used.

8. Undesirable Effects & Post-Market Data

  • Review of historical adverse events
  • Cosmetovigilance data
  • Literature safety review
  • Serious Undesirable Effects (SUE) documentation

Part B: Cosmetic Product Safety Assessment

Part B contains the formal expert safety conclusion prepared by a qualified safety assessor.

The assessor evaluates:

Assessment CriteriaRegulatory Consideration
Margin of Safety (MoS)MoS ≥ 100 typically required
Cumulative Ingredient ExposureMulti-product use scenarios
Vulnerable PopulationsChildren, pregnant women
Intended & Foreseeable UseRisk-benefit justification

The final statement must clearly conclude whether the product is safe under normal and reasonably foreseeable conditions of use.

Under EU law, the safety assessor must hold appropriate qualifications in toxicology, pharmacy, medicine, or a related scientific discipline.

Additional Compliance Requirements Linked to CPSR

Beyond CPSR preparation, companies must ensure:

  • Product Information File (PIF) maintenance
  • CPNP notification prior to market placement
  • Responsible Person designation within the EU
  • Claims substantiation under EU Regulation 655/2013
  • Compliance with labeling requirements

Emerging Regulatory Trends in EU Cosmetics (2025 Update)

The EU cosmetic regulatory landscape continues to evolve:

  • Increased scrutiny of endocrine disruptors
  • Microplastics restriction proposals
  • Sustainability and green claims verification
  • Stricter fragrance allergen labeling requirements
  • Enhanced cosmetovigilance reporting expectations

Staying ahead of these changes requires continuous regulatory monitoring.

Why Choose Maven Regulatory Solutions for CPSR Preparation?

Maven Regulatory Solutions offers comprehensive EU cosmetic compliance services, including:

  • Complete CPSR authoring (Part A & Part B)
  • Toxicological risk assessment
  • Ingredient compliance verification
  • Stability and microbial testing coordination
  • Margin of Safety calculations
  • PIF compilation support
  • CPNP notification assistance
  • EU Responsible Person support

Our multidisciplinary team ensures:

  • Scientific accuracy
  • Regulatory compliance
  • Accelerated market access
  • Risk mitigation

Strategic Benefits of Professional CPSR Support

Partnering with Maven enables:

  • Reduced regulatory risk
  • Faster EU market entry
  • Stronger brand credibility
  • Compliant safety documentation
  • Efficient audit readiness

In the competitive EU cosmetics market, a robust CPSR is not just a regulatory obligation   it is a strategic asset.

Conclusion

Preparing a Cosmetic Product Safety Report under Regulation (EC) No 1223/2009 requires detailed scientific documentation, toxicological expertise, and regulatory precision. From ingredient assessment to final safety conclusion, each component of the CPSR must withstand regulatory scrutiny.

Maven Regulatory Solutions provides expert CPSR preparation services to ensure cosmetic products meet all EU compliance requirements. By combining toxicological expertise, laboratory coordination, and regulatory strategy, we help brands confidently enter and succeed in the European cosmetics market.

Frequently Asked Questions (FAQs)

1. Is CPSR mandatory for all cosmetic products sold in the EU?

Yes. Every cosmetic product placed on the EU market must have completed CPSR as part of its Product Information File.

2. Who can prepare and sign Part B of a CPSR?

I am a qualified safety assessor with relevant academic credentials in toxicology, pharmacy, medicine, or related sciences.

3. What is Margin of Safety (MoS)?

MoS is the ratio between the No Observed Adverse Effect Level (NOAEL) and estimated exposure. An MoS ≥ 100 is typically considered acceptable.

4. How long does CPSR preparation take?

Timelines depend on data availability, required testing, and formulation complexity.

5. Does Maven assist with CPNP notification and Responsible Person services?

Yes. Maven provides end-to-end EU cosmetic compliance support, including CPSR, PIF compilation, and CPNP notification.